We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 269 results
  1. Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies

    Frontotemporal lobar degeneration (FTLD) is a group of disorders characterized by degeneration of the frontal and temporal lobes, leading to...

    Shunsuke Koga, Aya Murakami, ... Dennis W. Dickson in Acta Neuropathologica Communications
    Article Open access 06 July 2023
  2. Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer’s disease

    Alzheimer’s disease (AD), characterized by the deposition of amyloid-β (Aβ) in senile plaques and neurofibrillary tangles of phosphorylated tau...

    Ana-Caroline Raulin, Sydney V. Doss, ... Takahisa Kanekiyo in Acta Neuropathologica Communications
    Article Open access 09 February 2024
  3. Argyrophilic grain disease is common in older adults and may be a risk factor for suicide: a study of Japanese forensic autopsy cases

    Background

    Neuropathological diagnosis of argyrophilic grain disease (AGD) is currently based primarily on the combination of argyrophilic grain (AG)...

    Koji Yoshida, Yukiko Hata, ... Naoki Nishida in Translational Neurodegeneration
    Article Open access 01 April 2023
  4. Sha** the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models

    The transcellular propagation of the aberrantly modified protein tau along the functional brain network is a key hallmark of Alzheimer's disease and...

    Neha Basheer, Luc Buee, ... Norbert Zilka in Acta Neuropathologica Communications
    Article Open access 04 April 2024
  5. The Spectrum of Tau Pathology in Human Prion Disease

    Intracellular deposition of hyperphosphorylated tau characterizes tauopathies: there is a spectrum from neuron-predominant through mixed neuronal and...
    Gabor G. Kovacs, Herbert Budka in Prions and Diseases
    Chapter 2023
  6. Pretectum p1 (Prosomere 1)

    Structures dealt with in this chapter according to genoarchitectonical reasons no longer can be summarized under the term brainstem (Watson et al.,...
    Hannsjörg Schröder, Rob A. I. de Vos, ... Natasha Moser in The Human Brainstem
    Chapter 2023
  7. Neuritic Plaques — Gateways to Understanding Alzheimer’s Disease

    Extracellular deposits of amyloid-β (Aβ) in the form of plaques are one of the main pathological hallmarks of Alzheimer’s disease (AD). Over the...

    Wangchen Tsering, Stefan Prokop in Molecular Neurobiology
    Article Open access 08 November 2023
  8. Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels

    Background

    Advances in ultrasensitive detection of phosphorylated tau (p-tau) in plasma has enabled the use of blood tests to measure Alzheimer’s...

    Melissa E. Murray, Christina M. Moloney, ... Michelle M. Mielke in Molecular Neurodegeneration
    Article Open access 27 December 2022
  9. Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer’s disease and other neurodegenerative diseases

    Recent studies suggest that increased cerebrospinal fluid (CSF) phospho-tau is associated with brain amyloid pathology rather than the tau pathology....

    Masanori Kurihara, Tomoyasu Matsubara, ... Yuko Saito in Acta Neuropathologica Communications
    Article Open access 27 March 2024
  10. Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease

    The methionine (M)—valine (V) polymorphic codon 129 of the prion protein gene ( PRNP ) plays a central role in both susceptibility and phenotypic...

    Ellen Gelpi, Simone Baiardi, ... Piero Parchi in Acta Neuropathologica Communications
    Article Open access 17 August 2022
  11. Pathogenesis of Alzheimer’s Disease

    Alzheimer’s disease (AD) is a clinically progressive decline in cortical function involving memory and other cognitive domain of executive function...
    Rudy J. Castellani, Germán Plascencia-Villa, George Perry in Handbook of Neurotoxicity
    Reference work entry 2022
  12. Axonal degeneration in the anterior insular cortex is associated with Alzheimer’s co-pathology in Parkinson’s disease and dementia with Lewy bodies

    Background

    Axons, crucial for impulse transmission and cellular trafficking, are thought to be primary targets of neurodegeneration in Parkinson’s...

    Yasmine Y. Fathy, Laura E. Jonkman, ... Wilma D. J. van de Berg in Translational Neurodegeneration
    Article Open access 07 December 2022
  13. Comparison of Neuroinflammation Induced by Hyperphosphorylated Tau Protein Versus Ab42 in Alzheimer’s Disease

    Both neurofibrillary tangles and senile plaques are associated with inflammation in Alzheimer’s disease (AD). Their relative degree of induced...

    Madison Rice, Gerard J. Nuovo, ... Esmerina Tili in Molecular Neurobiology
    Article 18 December 2023
  14. Identification of clinical disease trajectories in neurodegenerative disorders with natural language processing

    Neurodegenerative disorders exhibit considerable clinical heterogeneity and are frequently misdiagnosed. This heterogeneity is often neglected and...

    Nienke J. Mekkes, Minke Groot, ... Inge R. Holtman in Nature Medicine
    Article Open access 12 March 2024
  15. Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer’s disease: implications for biomarker development and therapeutic targeting

    Tauopathies are neurodegenerative diseases that typically require postmortem examination for a definitive diagnosis. Detecting neurotoxic tau...

    Liara Rizzi, Lea T. Grinberg in Acta Neuropathologica Communications
    Article Open access 28 February 2024
  16. Alternative splicing in neurodegenerative disease and the promise of RNA therapies

    Alternative splicing generates a myriad of RNA products and protein isoforms of different functions from a single gene. Dysregulated alternative...

    David Nikom, Sika Zheng in Nature Reviews Neuroscience
    Article 19 June 2023
  17. LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease

    It has become evident that Alzheimer’s Disease (AD) is not only linked to its hallmark lesions—amyloid plaques and neurofibrillary tangles (NFTs)—but...

    Marta J. Koper, Sandra O. Tomé, ... Dietmar Rudolf Thal in Acta Neuropathologica Communications
    Article Open access 03 September 2022
Did you find what you were looking for? Share feedback.